| RS1553788026 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1553788117 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS1553788596 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1553788733 |
COL6A6
|
Health Risk |
Likely pathogenic |
— |
| RS1553789166 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS1553789264 |
ZBTB20
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Primrose syndrome |
| RS1553789275 |
ZBTB20
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553794304 |
CEP19
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1553794464 |
ZBTB20
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553795301 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1553797598 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553798675 |
FGF12
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 47 |
| RS1553800956 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553801591 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1553801881 |
STAG1
|
Health Risk |
Pathogenic |
— |
| RS1553802038 |
ZNF148
|
Health Risk |
Likely pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS1553803235 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1553803540 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553804100 |
CCDC39
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553804209 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553804220 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553804640 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553805740 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553805885 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1553807905 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS1553808038 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS1553808267 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1553808295 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553808296 |
MYLK
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553808301 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 41 |
| RS1553809314 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS1553809654 |
CLDN16
|
Health Risk |
Pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS1553809971 |
TTN
|
Health Risk |
Pathogenic |
Early-onset myopathy with fatal cardiomyopathy, Early-onset myopathy with fatal cardiomyopathy |
| RS1553810149 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1553810244 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553810255 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 41 |
| RS1553810269 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
TBL1XR1-related disorder, TBL1XR1-related disorder |
| RS1553810271 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
TBL1XR1-related disorder, TBL1XR1-related disorder |
| RS1553810281 |
TBL1XR1
|
Health Risk |
Likely pathogenic |
— |
| RS1553810330 |
PDE6B
|
Health Risk |
Likely pathogenic |
— |
| RS1553811551 |
RPL35A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS1553811652 |
DVL3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1553811863 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1553812417 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1553812554 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553813646 |
TBL1XR1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 41 |
| RS1553815019 |
EVC2
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Ellis-van Creveld syndrome |
| RS1553815325 |
MED12L
|
Health Risk |
Likely pathogenic |
— |
| RS1553815393 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Pierpont syndrome |
| RS1553816164 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pierpont syndrome, Pierpont syndrome |
| RS1553818428 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553820381 |
PIK3CA
|
Health Risk |
Likely pathogenic |
— |
| RS1553820399 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome, PIK3CA related overgrowth syndrome |
| RS1553820434 |
TREX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, Chilblain lupus 1 |
| RS1553820461 |
TREX1
|
Health Risk |
Likely pathogenic |
— |
| RS1553820518 |
TREX1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 1, Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| RS1553821144 |
PIK3CA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Diffuse pediatric-type high-grade glioma |
| RS1553823547 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553825266 |
PIK3CA
|
Health Risk |
Pathogenic |
— |
| RS1553826166 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Endometrial carcinoma, PIK3CA-related disorder |
| RS1553826184 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS1553827236 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, Joubert syndrome 9 |
| RS1553827968 |
ALG3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, ALG3-congenital disorder of glycosylation |
| RS1553833239 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553836165 |
EVC2
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Curry-Hall syndrome |
| RS1553836169 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553837446 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1553840705 |
TP63
|
Health Risk |
Pathogenic |
— |
| RS1553840713 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1553842818 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1553845300 |
CC2D2A
|
Health Risk |
Pathogenic |
COACH syndrome 1, COACH syndrome 1 |
| RS1553845302 |
CC2D2A
|
Health Risk |
Pathogenic |
— |
| RS1553845515 |
TP63
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553845569 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553845917 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1553846331 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS1553846613 |
EVC2
|
Health Risk |
Pathogenic |
— |
| RS1553847587 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1553847993 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1553848441 |
PDHB
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS1553849789 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1553849875 |
EVC2
|
Health Risk |
Likely pathogenic |
— |
| RS1553849894 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553849919 |
DNAJB11
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS1553849920 |
DNAJB11
|
Health Risk |
Pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS1553850100 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS1553850185 |
DNAJB11
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 6 with or without polycystic liver disease, Polycystic kidney disease 6 with or without polycystic liver disease |
| RS1553850609 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1553850677 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553851245 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1553851462 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553851490 |
GNB4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS1553851860 |
CPLX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 63 |
| RS1553851870 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1553852469 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1553852691 |
MASP1
|
Health Risk |
Likely pathogenic |
— |
| RS1553852989 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553853012 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553853022 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa pruriginosa, autosomal dominant |
| RS1553853065 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |